Blood gene expression signatures predict exposure levels

Abstract

To respond to potential adverse exposures properly, health care providers need accurate indicators of exposure levels. The indicators are particularly important in the case of acetaminophen (APAP) intoxication, the leading cause of liver failure in the U.S. We hypothesized that gene expression patterns derived from blood cells would provide useful indicators of acute exposure levels. To test this hypothesis, we used a blood gene expression data set from rats exposed to APAP to train classifiers in two prediction algorithms and to extract patterns for prediction using a profiling algorithm. Prediction accuracy was tested on a blinded, independent rat blood test data set and ranged from 88.9% to 95.8%. Genomic markers outperformed predictions based on traditional clinical parameters. The expression profiles of the predictor genes from the patterns extracted from the blood exhibited remarkable (97% accuracy) transtissue APAP exposure prediction when liver gene expression data were used as a test set. Analysis of human samples revealed separation of APAP-intoxicated patients from control individuals based on blood expression levels of human orthologs of the rat discriminatory genes. The major biological signal in the discriminating genes was activation of an inflammatory response after exposure to toxic doses of APAP. These results support the hypothesis that gene expression data from peripheral blood cells can provide valuable information about exposure levels, well before liver damage is detected by classical parameters. It also supports the potential use of genomic markers in the blood as surrogates for clinical markers of potential acute liver damage.acetaminophen ͉ hepatotoxicity ͉ microarray ͉ prediction ͉ genomics

Identification of gene expression signature for cigarette smoke exposure response—from man to mouse

“…20 A more global picture of the impacted biology can be achieved by gene expression studies, and various exposures have been shown to alter gene expression profiles in blood. [21][22][23] Indeed, several studies have shown that gene expression in blood can distinguish between average subject populations, such as those with early stage non-small cell lung cancer, from those with non-malignant lung disease, 24,25 subjects with chronic obstructive pulmonary disease (COPD) from healthy smokers, 26 and even smokers with no detectable disease from nonsmokers. [27][28][29][30][31][32][33] A transcriptome-based exposure response signature could be as simple as the presence or absence of a single gene expression, or, more likely, could be characterized by the expression levels of a collection of genes, each contributing to a specific diagnosis.…”

Complement Receptor 1 Expression in Peripheral Blood Mononuclear Cells and the Association with Clinicopathological Features And Prognosis of Nasopharyngeal Carcinoma

“…Furthermore, because of their clinical accessibility, circulating blood cells are very useful for assessing disease-related changes in gene expression. Bushel et al have shown that gene expression data from PBMCs can predict environmental exposure levels (Bushel et al, 2007). Because most diseases, including cancers, result from interactions between genetic and environmental factors, gene expression data for PBMCs can be used as biomarkers for the early detection of diseases and for the identification of clinicopathological features and estimation of prognosis.…”

Acute and chronic paracetamol overdose in paediatric population: Protocol of a prospective study of cohort to evaluate clinic factor and biomarkers to predict development of hepatotoxicity

“…Gene expression can provide information that refl ects the physiological status of the body. Bushel et al (27) confi rmed the hypothesis that gene expression patterns derived from peripheral blood cells could predict the degree of liver injury following an acute overdose of paracetamol before it can be detected by traditional parameters. Analysis of the genes revealed more alteration in the infl ammatory pathways involving IL-1 and NF-kB.…”